Evidence map›Paper›PMID 38416334›Full record

ArticleMaternal and child health journal2024

Birth Outcomes Among People with Hepatitis C in Pregnancy - Three U.S. States, 2018-2021.

Kate R Woodworth, Suzanne M Newton, Ayzsa Tannis, Megan R Reynolds, Emily O Olsen, Lindsey Sizemore, Heather Wingate, Lauren Orkis, Bethany Reynolds, Nicole Longcore and 7 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Maternal and child health journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Kate R WoodworthDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA. setnet@cdc.gov.ORCID http://orcid.org/0000-0001-9343-3355
Suzanne M NewtonDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ayzsa TannisEagle Global Scientific, LLC, San Antonio, TX, USA.
Megan R ReynoldsDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Emily O OlsenDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lindsey SizemoreTennessee Department of Health, Nashville, TN, USA.
Heather WingateTennessee Department of Health, Nashville, TN, USA.
Lauren OrkisPennsylvania Department of Health, Pittsburgh, PA, USA.
Bethany ReynoldsPennsylvania Department of Health, Pittsburgh, PA, USA.
Nicole LongcoreNew York State Department of Health, Albany, NY, USA.
Nadia ThomasNew York State Department of Health, Albany, NY, USA.
Shin Y KimDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lakshmi PanagiotakopoulosDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Carolyn WesterDivision of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Dana Meaney DelmanDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Suzanne M GilboaDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Van T TongDivision of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Centers for Disease Control and Prevention · USNew York State Department of Health · USPennsylvania Department of Health · USTennessee Department of Health · US

Funding

Intramural CDC HHS CC999999NCEZID CDC HHS CK19-1904
6 · The paper itself

Abstract

introductionThere are limited and conflicting data regarding the impact of hepatitis C in pregnancy on adverse birth outcomes.

methodsUsing the Surveillance for Emerging Threats to Pregnant People and Infants Network (SET-NET), a large surveillance cohort, we describe birth outcomes among a cohort of people with HCV in pregnancy in total and by reported substance use.

resultsAmong 1418 infants, 89% were born to people with reported substance use during pregnancy. The proportion born preterm was 20%, 13% were small-for-gestational age and 34% of term infants required intensive care.

conclusionsAssessments of recent changes to recommendations for HCV screening in pregnancy should evaluate the impact on maternal access to care for both HCV treatment as well as comorbidities such as substance use disorder which may contribute to adverse birth outcomes.

Indexed as

Hepatitis CPregnancy Complications, InfectiousPregnancy OutcomeAdultCohort StudiesFemaleHumansInfant, NewbornPregnancyPremature BirthUnited StatesAdverse pregnancy outcomesHepatitis CPreterm birthSubstance use

Identifiers

PMID38416334
PMCPMC11060891
OpenAlexW4392234171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.